Letters Corresponding Author: Nonniekaye Shelburne, CRNP, MS, AOCN, Division of CORRECTION Cancer Control and Population Sciences, National Cancer Institute, 9609 Data Presentation Error in Results Paragraph of Abstract: In the Original Inves- Medical Center Dr, Room 4E110, Rockville, MD 20850 (firstname.lastname@example.org). tigation titled “Comparison Between Adjuvant and Early-Salvage Postprostatec- Published Online: March 1, 2018. doi:10.1001/jamaoncol.2017.5534 tomy Radiotherapy for Prostate Cancer With Adverse Pathological Features,” pub- Conflict of Interest Disclosures: None reported. lished online January 25, 2018, there was an error in the data presented in the 1. Rivera DR, Gallicchio L, Brown J, Liu B, Kyriacou DN, Shelburne N. Trends in ResultsparagraphoftheAbstract.Inthefirstsentenceofthatparagraph,theranges adult cancer-related emergency department utilization: an analysis of data from of prostate-specific antigen levels were reversed. It should read as follows: “Of 1566 the Nationwide Emergency Department Sample. JAMA Oncol. 2017;3(10):e172450. patients,1195withprostate-specificantigenlevelsof0.1to0.5ng/mLreceivedESRT and 371 patients with prostate-specific antigen levels lower than 0.1 ng/mL re- 2. Healthcare Cost and Utilization Project (HCUP). HCUP Nationwide ceived ART.” This article has been corrected online. Emergency Department Sample (NEDS). Rockville, MD: Agency for Healthcare Research and Quality. https://www.hcup-us.ahrq.gov/nedsoverview.jsp. Accessed January 31, 2018. 1. Hwang WL, Tendulkar RD, Niemierko D, et al. Comparison between adjuvant 3. Greene J. CONCERN for cancer: new National Institutes of Health network to and early-salvage postprostatectomy radiotherapy for prostate cancer with focus on cancer patients in the emergency department. Ann Emerg Med. 2015; adverse pathological features [published online January 25, 2018]. JAMA Oncol. 66(1):13A-15A. doi:10.1001/jamaoncol.2017.5230 jamaoncology.com (Reprinted) JAMA Oncology May 2018 Volume 4, Number 5 751 © 2018 American Medical Association. All rights reserved.
JAMA Oncology – American Medical Association
Published: May 22, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera